A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections

The objective of this study is to evaluate the efficacy of intravenous micafungin for the empirical antifungal therapy, pre-emptive antifungal therapy, diagnostic driven antifungal therapy or targeted antifungal therapy patients with invasive fungal infections caused by Candida sp. or Aspergillus sp. (fungemia, respiratory mycosis, gastrointestinal mycosis) in adult patients in China.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Invasive Fungal Infections Aspergillosis Bacterial Infections and Mycoses Infections Mycoses Torulopsis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who received Micafungin as empirical antifungal therapy, pre-emptive antifungal therapy, diagnostic driven antifungal therapy or targeted antifungal therapy
Patients received Micafungin treatment at least 1 dose

Exclusion criteria

Patients received Micafungin treatment combined with other antifungal drugs at the same time
Neither efficacy or safety can be evaluated because of missing data, confused record

Treatment and study plan

Micafungin

Drug

Intravenous

Primary outcomes

Overall success rate

Time frame: Up to 12 months

Overall success rate=number of overall success patients/number of patients for efficacy evaluation × 100%

Secondary outcomes

Overall incidence and severity of adverse events

Time frame: Up to 12 months
Overall incidence and severity of adverse drug reactions

Time frame: Up to 12 months

Sponsors and collaborators

Lead sponsor

Astellas Pharma China, Inc.

Industry

Registry information

Important dates

Study start: 2015
Primary completion: 2015
Study completion: 2015
First posted: Feb 10, 2016
Registry last updated: Feb 10, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed